Clinical Trial Update: A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes a single ascending dose study of BMS-650032 in adults with hepatitis C, covering Phase 1/2, whose status is listed as comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BMS-650032

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED